Designing Personalized Antigen-Specific Immunotherapies for Autoimmune Diseases—The Case for Using Ignored Target Cell Antigen Determinants

We have proposed that antigen-specific immunotherapies (ASIs) for autoimmune diseases could be enhanced by administering target cell antigen epitopes (determinants) that are immunogenic but ignored by autoreactive T cells because these determinants may have large pools of naïve cognate T cells avail...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Jide, Song, Min, Kaufman, Daniel L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997884/
https://www.ncbi.nlm.nih.gov/pubmed/35406645
http://dx.doi.org/10.3390/cells11071081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997884/
https://www.ncbi.nlm.nih.gov/pubmed/35406645
http://dx.doi.org/10.3390/cells11071081

Ejemplares similares